Identification of Molecular Pathways Facilitating Glioma Cell Invasion In Situ
Figure 5
OLIG2, PARD3 and EFNB3 expression in GBM patients.
Immunohistochemistry and H&E staining of matched tumor core (A, C, E) and AOI (B, D, F) specimens from GBM patients. Representative images for OLIG2 upregulation (A, B) and decreased expression of PARD3 (C, D) in the IGCs. EFNB3 expression (E, F) is enriched at the AOI. Magnification ×40.